• Topics

  • Formats

Organiser: MAPS

Published 11 August 2026

Author(s): Jon Dixon, Jennifer Sanfilippo, & Jessica Santos

Key Takeaways

  • AI adoption is expanding across Medical Affairs, increasing the need for responsible, transparent, and auditable AI practices.
  • Pharma companies remain accountable for AI outputs, even when AI systems or services are provided by third-party vendors and partners.
  • Strong governance is essential: Human oversight, data quality, validation, traceability, and transparency provide a durable foundation as AI regulations continue to evolve.

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?